Instituto de Diagnóstico S.A.

CL$2,293As of Sun 8 Nov 2026, 12:00 UTC
BCS:INDISAHealthcare
Country Chile
PE (Fwd) •••
TSR 10Y CAGR 2.02%
Div yield 0.68%
ROE 7.51%
Medical Care Facilities
Beta (5Y) 0.44
PE TTM 27.12
TSR TTM (12.46%)
Mkt cap CL$351.8B
ROIC 7.33%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2,808
22.48%
(57.69%)
Hold 5|3|4|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
49.46
53.41
54.13
60.56
4.65%
6.69%
10.79%
24.32%
Revenue$B
27.58
28.13
28.79
28.02
8.22%
11.82%
9.88%
5.17%
Peers (US$360.6M)
Cap (US$)
PE
366.6M
66.45x
364.6M
90.93x
355.3M
43.88x
Capital
TTM
5Y
10Y
Leveragex
1.364
0.185
0.177
EBIT/Intx
0.168
0.177
0.135
Own earn%
(5.35)
16.77
11.88
Sh yield%
40.94
43.78
41.73
Owners
Insiders/Inst%
2.22
79.15
Short interest%
2.33
SBC / revenue%
2.70
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
17–23
$1 testx
−0.1
Incr. ROIC%
36